ImmunoPET: concept, design, and applications
W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …
Matching chelators to radiometals for radiopharmaceuticals
Radiometals comprise many useful radioactive isotopes of various metallic elements. When
properly harnessed, these have valuable emission properties that can be used for …
properly harnessed, these have valuable emission properties that can be used for …
[HTML][HTML] Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs
Theranostics is an emerging paradigm that combines imaging and therapy in order to
personalize patient treatment. In nuclear medicine, this is achieved by using …
personalize patient treatment. In nuclear medicine, this is achieved by using …
Molecular targeting of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR)
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor
(VEGFR) are two extensively studied membrane-bound receptor tyrosine kinase proteins …
(VEGFR) are two extensively studied membrane-bound receptor tyrosine kinase proteins …
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
F Rösch, H Herzog, SM Qaim - Pharmaceuticals, 2017 - mdpi.com
In the context of radiopharmacy and molecular imaging, the concept of theranostics entails a
therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the …
therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the …
Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges
TK Nayak, MW Brechbiel - Bioconjugate chemistry, 2009 - ACS Publications
Radioimmunoimaging and therapy has been an area of interest for several decades. Steady
progress has been made toward clinical translation of radiolabeled monoclonal antibodies …
progress has been made toward clinical translation of radiolabeled monoclonal antibodies …
Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
S Bhattacharyya, M Dixit - Dalton transactions, 2011 - pubs.rsc.org
Metallic radionuclides are the mainstay of both diagnostic and therapeutic
radiopharmaceuticals. Therapeutic nuclear medicine is less advanced but has tremendous …
radiopharmaceuticals. Therapeutic nuclear medicine is less advanced but has tremendous …
Cancer radioimmunotherapy
RM Sharkey, DM Goldenberg - Immunotherapy, 2011 - Taylor & Francis
Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field
of research spanning nearly 50 years, evolving with advancing technologies in molecular …
of research spanning nearly 50 years, evolving with advancing technologies in molecular …
[HTML][HTML] Image guided biodistribution and pharmacokinetic studies of theranostics
H Ding, F Wu - Theranostics, 2012 - ncbi.nlm.nih.gov
Image guided technique is playing an increasingly important role in the investigation of the
biodistribution and pharmacokinetics of drugs or drug delivery systems in various diseases …
biodistribution and pharmacokinetics of drugs or drug delivery systems in various diseases …
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
This preliminary investigation of the octadentate acyclic chelator H4octapa (N4O4) with
111In/115In3+ has demonstrated it to be an improvement on the shortcomings of the current …
111In/115In3+ has demonstrated it to be an improvement on the shortcomings of the current …